Krishna Radhakrishnan

Krishna Radhakrishnan


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2009 in Carbohydrate Polymers
Verified
Journal Article
Closed access
AAA. Anitha
A. Anitha
VRV.V. Divya Rani
V.V. Divya Rani
KRKrishna Radhakrishnan
Krishna Radhakrishnan
VSV. Sreeja
V. Sreeja
NSN. Selvamurugan
N. Selvamurugan
Jayakumar RangasamyJayakumar Rangasamy
Jayakumar Rangasamy

1 September 2014 in Journal of Food Engineering
Verified
Journal Article
Closed access
MTMidhun Ben Thomas
Midhun Ben Thomas
MVMahalakshmi Vaidyanathan
Mahalakshmi Vaidyanathan
KRKrishna Radhakrishnan
Krishna Radhakrishnan
ARAshok M. Raichur
Ashok M. Raichur

1 February 2017 in Drug Discovery Today
Verified
Journal Article
Closed access
KRKrishna Radhakrishnan
Krishna Radhakrishnan
NSNirmal Sonali
Nirmal Sonali
MMMiguel Moreno
Miguel Moreno
JNJayabalan Nirmal
Jayabalan Nirmal
AFAlexandra A. Fernandez
Alexandra A. Fernandez
RARupesh Agrawal
Rupesh Agrawal

25 April 2013 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
KRKrishna Radhakrishnan
Krishna Radhakrishnan
JTJasaswini Tripathy
Jasaswini Tripathy
ARAshok M. Raichur
Ashok M. Raichur
Hollow microcapsules capable of disintegrating in response to dual biological stimuli have been synthesized from two FDA approved drug molecules. The capsules fabricated from protamine and chondroitin sulphate disintegrate in the presence of either trypsin or hyaluronidase enzymes, which are documented to be simultaneously over-expressed under some pathological conditions.

17 September 2014 in RSC Advances
Verified
Journal Article
Closed access
PDF file
KRKrishna Radhakrishnan
Krishna Radhakrishnan
JTJasaswini Tripathy
Jasaswini Tripathy
DGDivya P. Gnanadhas
Divya P. Gnanadhas
DCDipshikha Chakravortty
Dipshikha Chakravortty
ARAshok M. Raichur
Ashok M. Raichur
We report the fabrication of dual enzyme responsive hollow nanocapsules which can be targeted to deliver anticancer agents specifically inside cancer cells. The enzyme responsive elements, integrated in the nanocapsule walls, undergo degradation in the presence of either trypsin or hyaluronidase leading to the release of encapsulated drug molecules. These nanocapsules, which were crosslinked and functionalised with folic acid, showed minimal drug leakage when kept in pH 7.4 PBS buffer, but released the drug molecules at a rapid rate in the presence of either one of the triggering enzymes. Studies on cellular interactions of these nanocapsules revealed that doxorubicin loaded nanocapsules were taken up by cervical cancer cells via folic acid receptor medicated endocytosis. Interestingly the nanocapsules were able to disintegrate inside the cancer cells and release doxorubicin which then migrated into the nucleus to induce cell death. This study indicates that these nanocapsules fabricated from biopolymers can serve as an excellent platform for targeted intracellular drug delivery to cancer cells.

22 October 2013 in Particle & Particle Systems Characterization
Verified
Journal Article
Closed access
PDF file
KRKrishna Radhakrishnan
Krishna Radhakrishnan
SGSatyajit Gupta
Satyajit Gupta
DGDivya Prakash Gnanadhas
Divya Prakash Gnanadhas
PRPraveen C Ramamurthy
Praveen C Ramamurthy
DCDipshika Chakravortty
Dipshika Chakravortty
ARAshok M. Raichur
Ashok M. Raichur